| # | Drug | Count |
|---|---|---|
| 0 | OSIMERTINIB | 152 |
| 1 | GEFITINIB | 130 |
| 2 | AFATINIB | 88 |
| 3 | ERLOTINIB HYDROCHLORIDE | 69 |
| 4 | ERLOTINIB | 58 |
| 5 | CARBOPLATIN | 53 |
| 6 | PEMETREXED DISODIUM | 50 |
| 7 | PEMETREXED | 44 |
| 8 | BEVACIZUMAB | 30 |
| 9 | GEMCITABINE HYDROCHLORIDE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEFITINIB | 130 | 0.0145 |
| 1 | AFATINIB | 88 | 0.0133 |
| 2 | ERLOTINIB HYDROCHLORIDE | 69 | 0.0055 |
| 3 | VINORELBINE | 11 | 0.0016 |
| 4 | DACOMITINIB | 1 | 0.0013 |
| 5 | PEMETREXED DISODIUM | 50 | 0.0013 |
| 6 | PRALSETINIB | 1 | 0.0005 |
| 7 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 8 | CRIZOTINIB | 6 | 0.0005 |
| 9 | GEMCITABINE HYDROCHLORIDE | 24 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 285 | 0.0005 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 27 | 0.0003 |
| 3 | Platinum-based Drug [EPC] | 70 | 0.0003 |
| 4 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 6 | Microtubule Inhibitor [EPC] | 28 | 0.0002 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 30 | 0.0002 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 47 | 0.0001 |